However, the mutations in either gene in lung adenocarcinomas are rarely seen although the biological consequences of KRAS and EGFR mutations share similarities in regulation of cell proliferation, survival and apoptosis [47], [48]. The gene discussed is EGFR; the disease is lung adenocarcinoma.